JPRN-UMIN000029000尚未招募未知
On target management for secondary hyperparathyroidism by two calcimimetics (HP2C study) - HP2C study
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients with sever heart failure (>NYHA III),liver dysfunction, respiratory failure, and malignant tumor.
研究者
相似试验
已完成
4 期
The comparison of calcimimeticsChronic kidney diseaseJPRN-jRCTs051190014Kuragano Takahiro300
进行中（未招募）
不适用
Behandling af sekundær hyperparathyreoidisme hos uræmiske patienter.En sammenlignenede undersøgelse mellem virkningen af alfacalcidol og paricalcitol.EUCTR2006-005981-37-DKRoskilde Amts Sygehus
进行中（未招募）
不适用
TREATMENT OF HYPERPARATHYROIDISM IN PATIENTS WITH MULTIPLE ENDOCRINE NEOPLASIA TYPE 1 (MEN1) WITH THE CALCIMIMETIC AGENT CINACALCET - NDPrimary hyperparathyroidism in patients affected with multiple endocrine neoplasia syndrome type 1 (MEN1)MedDRA version: 9.1Level: LLTClassification code 10027180EUCTR2008-005055-23-ITOSPEDALE MAGGIORE DI MILANO (IRCCS)
已完成
不适用
Prevalence of Secondary Hyperparathyroidism Among Patients With Diabetic NephropathySecondary HyperparathyroidismDiabetic NephropathiesNCT03137316Benha University437
撤回
不适用
Surgical Approach for Primary Hyperparathyroidism in the ElderlyMultigland Disease in Primary HyperparathyroidismNCT01484379Rambam Health Care Campus